Skip to content

Midazolam

Overview

Field Detail
Drug class Benzodiazepine / Hypnotic agent
Stock vial 1 mg/mL or 5 mg/5 mL (1 mg/mL)
Reconstituted conc. N/A (Ready to use)
Storage Room temp; Protect from light

Preparation

Before you start

Ensure the vial contains 1 mg/mL. Check expiry and integrity. Note that older protocols used a higher concentration, but as of March 2020, use 1 mg/mL for all skin testing.

Equipment needed

  • 1 × Midazolam 1 mg/mL vial
  • Normal saline (NS) — for IDT dilutions
  • 1 mL syringes × 3 (for test doses)
  • 25 G needles

Step 1 — Prepare the SPT solution (1 mg/mL — neat)

  1. Draw up 0.5–1 mL of the stock (1 mg/mL) into a 1 mL syringe.
  2. Label: "Midazolam SPT 1 mg/mL".

Step 2 — Prepare IDT dilutions

Prepare in this order, using a fresh syringe for each step.

  1. IDT 0.01 mg/mL (1:100):
    • Draw 0.1 mL of stock (1 mg/mL) into a 1 mL syringe. Add 0.9 mL NS. Mix. (This is 0.1 mg/mL — 1:10).
    • Draw 0.1 mL of this 0.1 mg/mL into a new 1 mL syringe. Add 0.9 mL NS. Mix. (This is 0.01 mg/mL — 1:100).
    • Label: "Midazolam IDT 0.01 mg/mL".

Skin prick test (SPT)

Reagent Concentration
Test solution Neat (1 mg/mL)
Positive control Histamine 10 mg/mL
Negative control Normal saline

Interpretation: Wheal ≥3 mm vs negative control = positive.


Intradermal test (IDT)

Dilution series

Step Dilution Concentration Preparation
1 1:100 0.01 mg/mL 0.1 mL of 0.1 mg/mL + 0.9 mL NS

Protocol Note

Midazolam IDT at 1:10 (0.1 mg/mL) should only be performed if the history is highly suspicious and earlier steps are negative, due to the risk of irritant responses.

Inject: 0.05 mL intradermal. Read at 15–20 minutes.